854 Risk of Immunogenicity to a Subsequent Therapy Is the Highest During the First Year After a Switch in Therapy in Immunogenic Patients With Inflammatory Bowel Diseases
Year: 2021
Type: article
Source: Gastroenterology
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3160888486